Tenet Healthcare (THC) Earnings Analysis

Tenet Healthcare (THC) next reports earnings on 2026-07-24, consensus EPS 4.26 USD. Last quarter (2026-04-30) it beat with EPS 4.82 USD vs 4.17 USD est (+15.6%). It has beaten estimates in 4/4 recent quarters (100%). Trailing P/E 10.07.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does THC next report earnings?

Next earnings date2026-07-24
Consensus EPS estimate4.26 USD
Revenue estimate5.43B

THC earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-304.82 USD4.17 USD+15.6%Beat
2025-07-224.02 USD2.87 USD+40.1%Beat
2025-02-123.44 USD2.95 USD+16.6%Beat
2024-07-242.31 USD1.9 USD+21.6%Beat

Beat rate: 4/4 (100%) over reported quarters with consensus data.

THC valuation and analyst view

Trailing P/E10.07
Trailing EPS19.62 USD
Price / book3.52
Dividend yield0.00%
Market cap16.92B
Analyst consensusBuy (26 buy / 6 hold / 0 sell)
Avg price target239.17 USD

Related research pages

Frequently asked questions

When is Tenet Healthcare (THC)'s next earnings date?

Tenet Healthcare is next scheduled to report on 2026-07-24, with a consensus EPS estimate of 4.26 USD and revenue estimate of 5.43B.

Did THC beat earnings last quarter?

In its 2026-04-30 report, THC posted EPS of 4.82 USD versus a 4.17 USD estimate — a beat of 15.6%.

What is THC's earnings track record?

Over the last 4 reported quarters with consensus data, THC beat estimates 4 times (100%).

What is THC's current P/E ratio and EPS?

THC trades at a trailing P/E of 10.07 on trailing EPS of 19.619589636064102 USD.

What do analysts rate THC?

Analyst consensus is "Buy" across 32 ratings (0 strong buy, 26 buy, 6 hold, 0 sell, 0 strong sell). Average 12-month price target: 239.17 USD.